Olfactory Dysfunction as a Biomarker for Early Diagnosis of Cognitive Impairment in Patients With Type 2 Diabetes: A Systematic Review
Conclusions: Olfactory dysfunction could be a biomarker for early diagnosis of CI in T2DM. However, these alterations are highly heterogeneous and more studies that include neuroimaging need to be conducted.
Saved in:
| Main Authors: | Paula Ramos-Cazorla, Lina Carazo-Barrios, Jose A. Reyes-Bueno, Elena Sagües-Sesé, Carmen de Rojas-Leal, Miguel A. Barbancho, Francisco J. Garzón-Maldonado, C. de la Cruz-Cosme, Juan A. García-Arnés, Natalia García-Casares |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/9933957 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroinflammation causes mitral cell dysfunction and olfactory impairment in a multiple sclerosis model
by: Charlotte Schubert, et al.
Published: (2025-03-01) -
Diagnostics of Olfactory Impairment Using the Novel Olfactory Test Panoramic Smell Test
by: Tolstikhin, Y.V., et al.
Published: (2025-04-01) -
Neuro-olfactory dynamics: electroencephalographic insights into dysfunction
by: Francisco Alves de Sousa, et al.
Published: (2024-09-01) -
Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
by: Felipe García, et al.
Published: (2021-08-01) -
Editorial: Olfactory dysfunction in neurodegenerative diseases
by: Debanjan Dasgupta, et al.
Published: (2025-05-01)